![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 2296-5262|26|5|446-450
ISSN: 2296-5270
Source: Oncology Research and Treatment, Vol.26, Iss.5, 2003-11, pp. : 446-450
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
First-Line Chemotherapy in Advanced Ovarian Cancer: State of the Art and Future Aspects
Oncology Research and Treatment, Vol. 22, Iss. 4, 1999-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Irinotecan (CPT-11) and Cisplatin as First-Line Chemotherapy for Advanced Ovarian Cancer
Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oncology Research and Treatment, Vol. 27, Iss. 1, 2004-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Topotecan in the First-Line Treatment of Small-Cell Lung Cancer
Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-05 ,pp. :